# OSELTAMIVIR PHOSPHATE
> **ANDA214726** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-07-25
## Drug
- **FDA Application Number:** ANDA214726
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OSELTAMIVIR PHOSPHATE
- **Generic name:** Oseltamivir Phosphate
- **Active ingredients:** OSELTAMIVIR PHOSPHATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2022-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214726)
---
*AI Analytics · CC0 1.0*